Bionext Pharma Private Limited - Company Profile

It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 2004.
2004 Navi Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Bionext Pharma Private Limited

Bionext Pharma Private Limited, a active private limited company, was established on 16 September 2004 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MH2004PTC148628. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹4.20 M.

Formerly known as Amibhari Properties Private Limited. It upholds a active non-compliant status. Employing 4 professional, Its leadership includes Manoj Shivajirao Desai (Director), Prashant Shivajirao Desai (Director), Narendra Madhavi Pandurang (Director). Past directors included Manoj Shivajirao Desai, Prashant Shivajirao Desai, Narendra Madhavi Pandurang. It holds ₹6.50 Cr open charges and ₹16.96 Cr settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Plot No C-373, Midc, Ttc Industrial Area Pawane, Village Turbhe, Navi Mumbai, Maharashtra, 400705.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MH2004PTC148628

  • Registration Number

    148628

  • Incorporation Date

    16 September 2004

  • Authorized Capital

    ₹6.00 M

  • Paid-Up Capital

    ₹4.20 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.00 M
  • Paid Up Capital ₹ 4.20 M
  • Company Age 21 Year, 6 Months
  • Last Filing with ROC 31 Mar 2020
  • Open Charges ₹ 6.50 Cr
  • Satisfied Charges ₹ 16.96 Cr
  • Revenue Growth **** -73.01%
  • Profit Growth **** -11.82%
  • Ebitda **** 16.72%
  • Net Worth -64.48%
  • Total Assets -0.90%
Company report

Bionext Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bionext Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bionext Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Manoj Shivajirao Desai Director 25 Oct 2005 Current
Prashant Shivajirao Desai Director 25 Oct 2005 Current
Narendra Madhavi Pandurang Director 14 Jun 2013 Current
Chandan Kalpesh Sanghrajka Additional Director 21 Apr 2025 Current
Kalpesh Ashok Sanghrajka Additional Director 21 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Apr 2025 Past
Pramod Abcsdd Director 23 Apr 2025 Past
Pramod Abcsdd Director 23 Apr 2025 Past
Pramod Abcsdd Director 01 Nov 2014 Past
Pramod Abcsdd Director 03 Jul 2020 Past
Pramod Abcsdd Irp/Rp/Liquidator 02 Jul 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bionext Pharma.

Bionext Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 73.01% decrease. The company also saw a substantial fall in profitability, with a 11.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 64.48%.

Bionext Pharma revenue growth over time
Bionext Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -73.01%
*******
*******
*******
*******
Revenue from Operations
*******
 -73.01%
*******
*******
*******
*******
Total Assets
*******
 -0.90%
*******
*******
*******
*******
Profit or Loss
*******
 -11.82%
*******
*******
*******
*******
Net Worth
*******
 -64.48%
*******
*******
*******
*******
EBITDA
*******
 16.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bionext Pharma?

In 2018, Bionext Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹65,000,000.00

Satisfied Charges

₹169,550,000.00

Charges Breakdown by Lending Institutions
  • Others : 6.50 Cr
  • Parsik Janata Sahakari Bank Limited : 4.06 Cr
  • Gopinath Patil Parsik Janta Sahakari Bank : 3.25 Cr
  • Gopinath Patil Parsik Janata Sahakari Bank Limited : 1.70 Cr
  • Parsik Janta Sahakari Bank Limited : 0.95 Cr
  • Others : 0.50 Cr
Latest Charge Details
Date Lender Amount Status
28 Dec 2017 Others ₹6.50 Cr Satisfied
04 Feb 2015 Gopinath Patil Parsik Janta Sahakari Bank ₹1.50 Cr Satisfied
15 Feb 2014 Gopinath Patil Parsik Janta Sahakari Bank ₹1.25 Cr Satisfied
28 Sep 2012 Gopinath Patil Parsik Janta Sahakari Bank ₹5.00 M Satisfied
03 May 2011 Gopinath Patil Parsik Janata Sahakari Bank Limited ₹1.70 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Bionext Pharma?

Unlock and access historical data on people associated with Bionext Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bionext Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bionext Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bionext Pharma
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 28 Dec 2017 via Charge ID 100145792 with Others was fully satisfied on 11 Sep 2025. was completed.

  • Director Appointment

    The activity Chandan Kalpesh Sanghrajka was appointed as a Additional Director was appointed as a Additional Director on 21 Apr 2025 & has been associated with this company since 11 months 2 days . was completed.

  • Director Appointment

    Kalpesh Ashok Sanghrajka was appointed as a Additional Director was appointed as a Additional Director on 21 Apr 2025 & has been associated with this company since 11 months 2 days . was recorded as a recent event.

  • Annual General Meeting

    Bionext Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Bionext Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 65.00 M registered on 28 Dec 2017 with Charge ID 100145792 was modified on 16 Jan 2018. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bionext Pharma Private Limited?

The CIN of Bionext Pharma Private Limited is U24232MH2004PTC148628.

Where is Bionext Pharma Private Limited headquartered?

Bionext Pharma Private Limited is headquartered at Plot No C-373, Midc, Ttc Industrial Area Pawane, Village Turbhe, Navi Mumbai, Maharashtra, 400705.

When was Bionext Pharma Private Limited incorporated?

Bionext Pharma Private Limited was incorporated on 16 September 2004.

Who are the current directors of Bionext Pharma Private Limited?

The current directors of Bionext Pharma Private Limited are

What is the primary industry of Bionext Pharma Private Limited?

The primary industry of Bionext Pharma Private Limited is Manufacturing.

Is Bionext Pharma Private Limited a listed company?

Bionext Pharma Private Limited is unlisted.

What is the capital structure of Bionext Pharma Private Limited?

The authorized capital of Bionext Pharma Private Limited is ₹6.00 M, and the paid-up capital is ₹4.20 M.

What is the compliance status of Bionext Pharma Private Limited?

The compliance status of Bionext Pharma Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available